Closing of public offering of Argos Therapeutics

24-Feb-2014 - USA

Forbion Capital Partners announces that its portfolio company Argos Therapeutics has closed its initial public offering.

The initial public offering price was $8.00 per ordinary share. Argos' ordinary shares have listed on the NASDAQ Global Market and began trading under the symbol "ARGS" on 7 February 2014.

Other news from the department business & finance

More news from our other portals

So close that even
molecules turn red...